Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Assets (2016 - 2026)

Pediatrix Medical (MD) has disclosed Assets for 17 consecutive years, with $2.2 billion as the latest value for Q4 2025.

  • Quarterly Assets rose 4.37% to $2.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 billion through Dec 2025, up 4.37% year-over-year, with the annual reading at $2.2 billion for FY2025, 4.37% up from the prior year.
  • Assets for Q4 2025 was $2.2 billion at Pediatrix Medical, up from $2.2 billion in the prior quarter.
  • The five-year high for Assets was $2.7 billion in Q4 2021, with the low at $2.0 billion in Q1 2025.
  • Average Assets over 5 years is $2.3 billion, with a median of $2.3 billion recorded in 2023.
  • The sharpest move saw Assets plummeted 42.5% in 2021, then grew 5.9% in 2025.
  • Over 5 years, Assets stood at $2.7 billion in 2021, then decreased by 13.76% to $2.3 billion in 2022, then dropped by 5.45% to $2.2 billion in 2023, then decreased by 3.02% to $2.2 billion in 2024, then rose by 4.37% to $2.2 billion in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $2.2 billion, $2.2 billion, and $2.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.